Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Whole-Genome Sequencing for Copy Number Abnormalities in Multiple Myeloma Supersedes Karyotype Analysis and Fluorescent in Situ Hybridization

Mao Mao, Jiali Li, Shaobing Gao, Zhenling Li, Yinyin Chang, Xiangxiang He, Yuexin Cheng, Manqian Li, Chunxiao Yao, Shiyong Li, Dandan Zhu, Shichun Tu, Xi Zhang, Li Gao

Blood (2023) 142 (Supplement 1): 7171.

https://doi.org/10.1182/blood-2023-179732

Published: 2023

Journal Articles

Prompt Assessment of Tumor Load and Treatment Response in Patients with Lymphoma By a Blood-Based Multi-Omics Approach

Xinhua Wang, Zhiming Li, Yu Chang, Shiyong Li, Wei Wu, Fangyuan Chang, Yinyin Chang, Dandan Zhu, Mingzhi Zhang, Mao Mao

Blood (2022) 140 (Supplement 1): 6415–6416.

https://doi.org/10.1182/blood-2022-165642

Published: 2022

Journal Articles

Whole Genome Sequencing As an Unbiased and Simplified Approach to Molecular Karyotyping in AML/MDS

Xiaodong Lv, Tao Li, Dandan Zhu, Mengna Zhang, Yuexin CHENG, Zhenling Li, Yan Chen, Shiyong Li, Yinyin Chang, Mao Mao, Zunmin Zhu, Yongping Song

Blood (2021) 138 (Supplement 1): 4462.

https://doi.org/10.1182/blood-2021-144752

Published: 2021

Journal Articles

Integrating Circulating Tumor DNA Features and Plasma Protein Markers to Detected Early Lymphoid Neoplasm

Xinhua Wang, Yu Chang, Dandan Zhu, Shiyong Li, Shuaipeng Geng, Yinyin Chang, Yan Chen, Mao Mao, Mingzhi Zhang

Blood (2021) 138 (Supplement 1): 4489.

https://doi.org/10.1182/blood-2021-145683

Published: 2021

Journal Articles

Role of clonoSEQ ® , a Next-Generation Sequencing (NGS) Assay and PET/CT As a Measure of Minimal Residual Disease Negativity Among Patients with Multiple Myeloma

Ajay Nooka, MDMPH, Kyle Bradley, MD MS, Nisha Joseph, MD, Craig C Hofmeister, MDMPH, Madhav V. Dhodapkar, MD, Larry H. Boise, PhD, Sagar Lonial, MD FACP, Shiyong Li, MD PhD, Jonathan L. Kaufman, MD

Blood (2020) 136 (Supplement 1): 50–51.

https://doi.org/10.1182/blood-2020-143093

Published: 2020

NARROW

Whole-Genome Sequencing for Copy Number Abnormalities in Multiple Myeloma Supersedes Karyotype Analysis and Fluorescent in Situ Hybridization

Prompt Assessment of Tumor Load and Treatment Response in Patients with Lymphoma By a Blood-Based Multi-Omics Approach

Whole Genome Sequencing As an Unbiased and Simplified Approach to Molecular Karyotyping in AML/MDS

Integrating Circulating Tumor DNA Features and Plasma Protein Markers to Detected Early Lymphoid Neoplasm

Role of clonoSEQ ® , a Next-Generation Sequencing (NGS) Assay and PET/CT As a Measure of Minimal Residual Disease Negativity Among Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Whole-Genome Sequencing for Copy Number Abnormalities in Multiple Myeloma Supersedes Karyotype Analysis and Fluorescent in Situ Hybridization

Prompt Assessment of Tumor Load and Treatment Response in Patients with Lymphoma By a Blood-Based Multi-Omics Approach

Whole Genome Sequencing As an Unbiased and Simplified Approach to Molecular Karyotyping in AML/MDS

Integrating Circulating Tumor DNA Features and Plasma Protein Markers to Detected Early Lymphoid Neoplasm

Role of clonoSEQ ® , a Next-Generation Sequencing (NGS) Assay and PET/CT As a Measure of Minimal Residual Disease Negativity Among Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only